Skip to main content
. 2022 Aug 25;37(9):2061–2067. doi: 10.1007/s00384-022-04243-2

Table 1.

Demographics and clinical characteristics of patients in this study

Characteristics IHC ( −)
N (%)/mean ± sd
IHC (1 +)
N (%)/mean ± sd
IHC (2 +)
N (%)/mean ± sd
IHC (3 +)
N (%)/mean ± sd
Age (year) 60.35 ± 11.89 60.51 ± 11.61 60.24 ± 11.72 58.29 ± 10.39
Sex

   Male

   Female

1480 (60)

945 (40)

599 (65)

323 (35)

318 (65.7)

166 (34.3)

43 (54.4)

36 (45.6)

T stage

   T1

   T2

   T3

   T4

133 (5.5)

347 (14.3)

1566 (64.6)

379 (15.6)

34 (3.7)

128 (13.9)

631 (68.4)

129 (14)

22 (4.5)

67 (13.8)

335 (69.2)

60 (12.4)

7 (8.9)

9 (11.4)

52 (65.8)

11 (13.9)

N stage

   N0

   N1

   N2

1318 (54.4)

670 (27.6)

437 (18)

524 (56.8)

254 (27.6)

144 (15.6)

267 (55.2)

139 (28.7)

78 (16.1)

36 (45.6)

27 (34.2)

16 (20.3)

Distant metastasis

   Yes

   No

2084 (85.9)

341 (14.1)

765 (83)

157 (17)

390 (80.6)

94 (19.4)

69 (87.3)

10 (12.7)

TNM stage

   I

   II

   III

   IV

360 (14.9)

856 (35.3)

869 (35.8)

340 (14)

127 (13.8)

351 (38.1)

289 (31.3)

155 (16.8)

61 (12.6)

181 (37.4)

148 (30.6)

94 (19.4)

10 (12.7)

23 (29.1)

36 (45.6)

10 (12.7)

Vessel invasion

   Yes

   No

1489 (61.4)

936 (38.6)

595 (64.5)

327 (35.5)

310 (64)

174 (36)

37 (46.8)

42 (53.2)

Perineural invasion

   Yes

   No

1616 (66.6)

809 (33.4)

615 (66.7)

307 (33.3)

305 (63)

179 (37)

47 (59.5)

32 (40.5)

Tumor differentiation

   High

   Poor-moderate

2293 (94.6)

132 (5.4)

877 (95.1)

45 (4.9)

455 (94)

29 (6)

76 (96.2)

3 (3.8)

Total 2425 (62) 922 (23.6) 484 (12.4) 79 (2)